Special Issue "RNA Vaccines against Tropical and Emerging Infectious Diseases"

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 31 July 2019

Special Issue Editors

Guest Editor
Prof. Dr. Maria Elena Bottazzi

Associate Dean and Professor of Pediatric Tropical Medicine, National School of Tropical Medicine, Baylor College of Medicine, 1102 Bates St., Ste. 550, Houston, TX 77030, USA
Website | E-Mail
Interests: neglected tropical diseases; vaccines; parasitic diseases; helminths; protozoa; product development; hookworm; schistosomiasis; Chagas disease; Leishmaniasis; Onchocerciasis; Capacity building
Guest Editor
Dr. Jeroen Pollet

Assistant Professor of Pediatric Tropical Medicine, National School of Tropical Medicine, Baylor College of Medicine, 1102 Bates St., Ste. 550, Houston, TX 77030, USA
Website | E-Mail
Interests: neglected tropical diseases; vaccines; adjuvants; parasitic diseases; helminths; protozoa; product development; hookworm; schistosomiasis; Chagas disease; Leishmaniasis
Guest Editor
Mr. Leroy Versteeg

Senior Research Assistant, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates St., Ste. 550, Houston, TX 77030, USA
Website | E-Mail
Interests: neglected tropical diseases; vaccine development; human pathogens; host-parasite interactions; immunology; flow cytometry; immunoassay development; innovation in research; soil transmitted helminths; Chagas disease; Chikungunya
Guest Editor
Dr. Ulrich Strych

Associate Professor of Pediatric Tropical Medicine, National School of Tropical Medicine, Baylor College of Medicine, 1102 Bates St., Houston, TX 77030, USA
Website | E-Mail
Interests: neglected tropical diseases; vaccines; diagnostics; drug development; Project development
Guest Editor
Dr. Mohan-Vivekanandan Poongavanam

Senior Research Assistant, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates St., Houston, TX 77030, USA
Website | E-Mail
Interests: neglected tropical diseases; vaccines; analytical development; quality control; vaccine development
Guest Editor
Dr. Mashal Almutairi

1 .Research Associate, Texas Children’s Hospital Center for Vaccine development, Baylor College of Medicine, 1102 Bates St., Houston, TX 77030, USA
2. Assistant Professor, Pharmacology Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Website | E-Mail
Interests: neglected tropical diseases; vaccines; analytical development; quality control; vaccine development; antimicrobials; resistant bacteria; Chagas disease; Leishmaniasis, MERS

Special Issue Information

Dear Colleagues,

In today’s world, billions of people are at risk for infection from ancient and newly-emerging tropical infectious diseases. Vaccines have been shown to have an enormous impact on overcoming the global burden of diseases; however, because of both technologic limitations and economic realities, scarcely any new vaccines for these diseases have made successful transition from development into licensure. Therefore, the world remains burdened by high morbidity diseases, as well as underprepared for the next biological threat or pandemic.

Novel technologies, lowering the cost of goods and accelerating the process of vaccine development could help address these urgent problems. In this Special Issue, entitled “RNA Vaccines against Tropical and Emerging Infectious Diseases”, we will present a compilation of articles that will focus on the recent scientific and technical progress made in the field of mRNA vaccines targeting neglected and emerging tropical infectious diseases. We invite authors to share their knowledge and experience to highlight how mRNA technology can help to i) improve vaccine potency and safety, ii) accelerate vaccine development, and iii) lower the cost of research, development and manufacturing.

Prof. Dr. Maria Elena Bottazzi
Dr. Jeroen Pollet
Mr. Leroy Versteeg
Dr. Ulrich Strych
Dr. Mohan-Vivekanandan Poongavanam
Dr. Mashal Almutairi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 650 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Tropical diseases
  • Infectious diseases
  • Emerging Diseases
  • mRNA vaccine
  • mRNA technology
  • Public health
  • vaccine development

Published Papers

This special issue is now open for submission.
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top